Randomized, sham-controlled, clinical trial of repetitive transcranial magnetic stimulation for patients with Alzheimer’s dementia in Japan
BackgroundSeveral medications have been applied to Alzheimer’s dementia patients (AD) but their efficacies have been insufficient. The efficacy and safety of 4 weeks of repetitive transcranial magnetic stimulation (rTMS) in Japanese AD were evaluated in this exploratory clinical trial.MethodsForty-t...
Main Authors: | Youichi Saitoh, Koichi Hosomi, Tomoo Mano, Yasushi Takeya, Shinji Tagami, Nobuhiko Mori, Akiyoshi Matsugi, Yasutomo Jono, Hideaki Harada, Tomomi Yamada, Akimitsu Miyake |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-10-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2022.993306/full |
Similar Items
-
Can we predict the response to Galantamine in Alzheimer`s disease patients?
by: Carmen Gavan, et al.
Published: (2015-09-01) -
Latest Trends in Outcome Measures in Dementia and Mild Cognitive Impairment Trials
by: Divyani Garg, et al.
Published: (2022-07-01) -
Associations of neuroinflammatory parameters with clinical features in patients with mild cognitive impairment and dementia
by: Y. Zorkina, et al.
Published: (2022-06-01) -
A comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test in schizophrenia
by: Mia Rademeyer, et al.
Published: (2016-05-01) -
Screening for cognitive impairment in schizophrenia: A comparison between the Mini-Mental State Examination and the Montreal Cognitive Assessment Test
by: Selma Ercan Doğu, et al.
Published: (2023-03-01)